These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 8687049
21. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539 [Abstract] [Full Text] [Related]
22. Sneddon's syndrome associated with anticardiolipin antibody: a case report. Mutluer N, Yiğit A, Aydin N. Acta Neurol Belg; 1992 May; 92(4):234-8. PubMed ID: 1441902 [Abstract] [Full Text] [Related]
23. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME, Cabiedes J, Reyes E, Cabral AR. Rev Invest Clin; 2005 May; 57(4):563-71. PubMed ID: 16315641 [Abstract] [Full Text] [Related]
24. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J, Cabral AR, Alarcón-Segovia D. J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [Abstract] [Full Text] [Related]
25. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745 [Abstract] [Full Text] [Related]
26. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?]. Vaillant L, Larmande P, Arbeille B, Desveaux B, Gruel Y, Lorette G. Ann Dermatol Venereol; 1990 Sep; 117(12):925-30. PubMed ID: 2082786 [Abstract] [Full Text] [Related]
27. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
28. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA. Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252 [Abstract] [Full Text] [Related]
30. [Anti-mitochondrial antibodies type 5 are markers of antiphospholipid syndrome]. Laperche S, Abuaf N, Deschamps A, Homberg JC. Ann Biol Clin (Paris); 1994 Nov; 52(5):375-9. PubMed ID: 7856938 [Abstract] [Full Text] [Related]
31. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS. Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [Abstract] [Full Text] [Related]
32. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O. J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267 [Abstract] [Full Text] [Related]
33. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR. J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654 [Abstract] [Full Text] [Related]
34. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus]. Pozsonyi T, Lakos G, Jakab L, Baraczka K, Jánoskuti L, Kleiber M, Sipka S, Pajor A, Szegedi G. Orv Hetil; 1998 Oct 04; 139(40):2363-8. PubMed ID: 9796352 [Abstract] [Full Text] [Related]
35. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant]. Kalashnikova LA, Prudnikova LZ, Nasonov EP. Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Oct 04; 90(7):104-7. PubMed ID: 2175072 [Abstract] [Full Text] [Related]
36. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. Sebastiani GD, Galeazzi M, Tincani A, Piette JC, Font J, Allegri F, Mathieu A, Smolen J, de Ramon Garrido E, Fernandez-Nebro A, Jedryka-Goral A, Papasteriades C, Morozzi G, Bellisai F, De Pitá O, Marcolongo R. Scand J Rheumatol; 1999 Oct 04; 28(6):344-51. PubMed ID: 10665739 [Abstract] [Full Text] [Related]
37. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome. Cabral AR, Cabiedes J, Alarcón-Segovia D. J Rheumatol; 1995 Oct 04; 22(10):1894-8. PubMed ID: 8991988 [Abstract] [Full Text] [Related]
38. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Reshetniak TM, Derksen RV, Alekberova ZS, Horbach D, De Groot F, Nasonov EL, Kalashnikova LA, Match ES, Nasonova VA. Klin Med (Mosk); 1998 Oct 04; 76(3):36-40. PubMed ID: 9575746 [Abstract] [Full Text] [Related]
39. Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I? Gharavi AE, Harris EN, Sammaritano LR, Pierangeli SS, Wen J. J Lab Clin Med; 1993 Oct 04; 122(4):426-31. PubMed ID: 8228557 [Abstract] [Full Text] [Related]
40. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr 04; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]